Logo image of RVC-P.CA

RONIN VENTURES CORP (RVC-P.CA) Stock Fundamental Analysis

TSX-V:RVC-P - TSX Venture Exchange - CA7763311007 - Common Stock - Currency: CAD

0.045  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RVC-P. RVC-P was compared to 0 industry peers in the Unkown industry. While RVC-P has a great health rating, there are worries on its profitability. RVC-P is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

RVC-P had negative earnings in the past year.
In the past year RVC-P has reported a negative cash flow from operations.
RVC-P.CA Yearly Net Income VS EBIT VS OCF VS FCFRVC-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20K -40K -60K -80K -100K

1.2 Ratios

Industry RankSector Rank
ROA -37.86%
ROE -40.09%
ROIC N/A
ROA(3y)-32.08%
ROA(5y)N/A
ROE(3y)-35.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RVC-P.CA Yearly ROA, ROE, ROICRVC-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

RVC-P does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVC-P.CA Yearly Profit, Operating, Gross MarginsRVC-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

7

2. Health

2.1 Basic Checks

The number of shares outstanding for RVC-P remains at a similar level compared to 1 year ago.
There is no outstanding debt for RVC-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RVC-P.CA Yearly Shares OutstandingRVC-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 1M 2M 3M 4M
RVC-P.CA Yearly Total Debt VS Total AssetsRVC-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50K 100K 150K

2.2 Solvency

RVC-P has an Altman-Z score of 16.76. This indicates that RVC-P is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for RVC-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.76
ROIC/WACCN/A
WACCN/A
RVC-P.CA Yearly LT Debt VS Equity VS FCFRVC-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50K -50K 100K 150K

2.3 Liquidity

RVC-P has a Current Ratio of 18.25. This indicates that RVC-P is financially healthy and has no problem in meeting its short term obligations.
RVC-P has a Quick Ratio of 18.25. This indicates that RVC-P is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 18.25
Quick Ratio 18.25
RVC-P.CA Yearly Current Assets VS Current LiabilitesRVC-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50K 100K 150K

0

3. Growth

3.1 Past

RVC-P shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.09%, which is quite impressive.
EPS 1Y (TTM)81.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

RVC-P reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVC-P.CA Price Earnings VS Forward Price EarningsRVC-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVC-P.CA Per share dataRVC-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RVC-P!.
Industry RankSector Rank
Dividend Yield N/A

RONIN VENTURES CORP

TSX-V:RVC-P (4/23/2025, 7:00:00 PM)

0.045

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners55.56%
Ins Owner ChangeN/A
Market Cap202.50K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB 1.81
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.86%
ROE -40.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.08%
ROA(5y)N/A
ROE(3y)-35.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 18.25
Quick Ratio 18.25
Altman-Z 16.76
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.12%
OCF growth 3YN/A
OCF growth 5YN/A